Somayeh Sadat Mehrnia

Somayeh Sadat Mehrnia

Auto-generated profile, based on publicly available information

Somayeh Sadat Mehrnia

Department of Integrative Oncology, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Physica Medica
Verified
Journal Article
Closed access
SMSomayeh Sadat Mehrnia
Somayeh Sadat Mehrnia
BHBijan Hashemi
Bijan Hashemi
SMSeyed Javad Mowla
Seyed Javad Mowla
AAAzim Arbabi
Azim Arbabi

9 January 2026 in Physics in Medicine & Biology
Verified
Journal Article
Open access
AGArman Gorji
Arman Gorji
Nima SanatiNima Sanati
Nima Sanati
APAmir Hossein Pouria
Amir Hossein Pouria
SMSomayeh Sadat Mehrnia
Somayeh Sadat Mehrnia
IHIlker Hacihaliloglu
Ilker Hacihaliloglu
MSMohammad R. Salmanpour
Mohammad R. Salmanpour
Objective: Radiomics-based AI models show potential in breast cancer diagnosis but lack interpretability. This study bridges the gap between radiomic features (RF) and BI-RADS descriptors through a clinically interpretable framework. Methods: We developed a dual-dictionary approach. First, a Clinical Mapping Dictionary (CMD) was constructed by mapping 56 RFs to BI-RADS descriptors (shape, margin, internal enhancement) based on literature and expert review. Second, we applied this framework to a classification task to predict triple-negative (TNBC) versus non-TNBC subtypes using Dynamic Contrast-Enhanced MRI data from a multi-institutional cohort of 1,549 patients. We trained 27 machine learning classifiers with 27 feature selection methods. Using SHapley Additive exPlanations (SHAP), we interpreted the model's predictions and developed a Statistical Mapping Dictionary (SMD) for 51 RFs, not included in the CMD. Results: The best-performing model (Variance Inflation Factor feature selector+Extra Trees Classifier) achieved an average cross-validation accuracy of 0.83±0.02. Our dual-dictionary approach successfully translated predictive RFs into understandable clinical concepts. For example, higher values of 'Sphericity', corresponding to a round/oval shape, were predictive of TNBC. Similarly, lower values of 'Busyness', indicating more homogeneous internal enhancement, were also associated with TNBC, aligning with existing clinical observations. This framework confirmed known imaging biomarkers and identified novel, data-driven quantitative features. Conclusion: This study introduces a novel dual-dictionary framework (BM1.0) that bridges RFs and the BI-RADS clinical lexicon. By enhancing the interpretability and transparency of AI models, the framework supports greater clinical trust and paves the way for integrating RFs into breast cancer diagnosis and personalized care.

10 June 2026 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
MSMohammad R. Salmanpour
Mohammad R. Salmanpour
APAmir Hossein Pouria
Amir Hossein Pouria
SFSonya Falahati
Sonya Falahati
STShahram Taeb
Shahram Taeb
SMSomayeh Sadat Mehrnia
Somayeh Sadat Mehrnia
ARArman Rahmim
Arman Rahmim
Objective: Computed tomography (CT) imaging is essential for lung cancer (LCa) management, while offering detailed visualization and valuable information for Artificial Intelligence-guided prognosis. Meanwhile, supervised learning (SL) models require extensive labeled data, limiting their real-world utility where annotations are scarce. Methods: We analyzed CT scans from 977 patients across 12 public/private datasets, extracting 1,218 radiomics features using Laplacian of Gaussian and wavelet filters via standardized PyRadiomics. Dimensionality was reduced using 56 feature selection and attribute extraction algorithms, and 27 classifiers were benchmarked. Semi-supervised learning (SSL) framework with pseudo-labeling utilized 478 unlabeled and 499 labeled cases. Model sensitivity was assessed in three scenarios: varying labeled data in SL, increasing unlabeled data in SSL, and jointly scaling both from 10% to 100%. SHapley Additive exPlanations analysis (SHAP)analysis explained and interpreted the top model predictions. Five-fold cross-validation and external testing (in two cohorts) were performed. Results: SSL outperformed SL across all metrics, improving overall survival prediction by up to 17%. The top SSL model (Feature Importance by Random Forest+XGBoost) achieved 0.90±0.01 accuracy in cross-validation and 0.88±0.01 externally. SHAP revealed enhanced feature discriminability in SSL and SL, particularly for class 1 (survival>4 years), and helped explain model decisions. SSL maintained strong performance even with only 10% labeled data. Both SSL-based scenarios demonstrated more stable performance compared to SL, with lower variance across external testing, emphasizing SSL's robustness and cost-efficiency. Conclusion: We propose an interpretable, cost-effective SSL framework for CT-based LCa survival prediction. Significance: It improves performance, generalizability, and clinical readiness via SHAP explainability and unlabeled data utilization.